{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T04:01:58Z","timestamp":1789704118913,"version":"4.0.1"},"reference-count":15,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[1990,11,1]],"date-time":"1990-11-01T00:00:00Z","timestamp":657417600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,2]],"date-time":"2015-12-02T00:00:00Z","timestamp":1449014400000},"content-version":"vor","delay-in-days":9162,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[1990,11]]},"DOI":"10.1111\/1523-1747.ep12505786","type":"journal-article","created":{"date-parts":[[2004,7,15]],"date-time":"2004-07-15T01:55:26Z","timestamp":1089856526000},"page":"S53-S55","source":"Crossref","is-referenced-by-count":23,"special_numbering":"S","title":["Cyclosporine A in the Treatment of Psoriasis: A Clinical and Mechanistic Perspective"],"prefix":"10.1016","volume":"95","author":[{"given":"Christopher E.M.","family":"Griffisths","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John J.","family":"Voorhees","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/1523-1747.ep12505786_bb0010","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1007\/BF01973261","article-title":"Biological effects of cyclosporin A: A new antilymphocytic agent","volume":"6","author":"Borel","year":"1976","journal-title":"Agents Act"},{"key":"10.1111\/1523-1747.ep12505786_bb0015","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1056\/NEJM197909063011015","article-title":"Cyclosporine A for psoriasis","volume":"301","author":"Mueller","year":"1979","journal-title":"N Engl J Med"},{"key":"10.1111\/1523-1747.ep12505786_bb0020","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1365-2133.1988.tb01768.x","article-title":"The pathomechanisms of psoriasis; the skin immune system and cyclosporin","volume":"118","author":"Bos","year":"1988","journal-title":"Br J Dermatol"},{"key":"10.1111\/1523-1747.ep12505786_bb0025","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/S0190-9622(89)70339-X","article-title":"Cyclosporine in dermatology","volume":"21","author":"Gupta","year":"1989","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/1523-1747.ep12505786_bb0030","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1365-2133.1989.tb07790.x","article-title":"Long term cyclosporin A for psoriasis","volume":"120","author":"Griffiths","year":"1989","journal-title":"Br J Dermatol"},{"key":"10.1111\/1523-1747.ep12505786_bb0035","first-page":"1234","article-title":"Cyclosporin hypertension","volume":"11","year":"1988","journal-title":"Lancet"},{"key":"10.1111\/1523-1747.ep12505786_bb0040","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0140-6736(88)91335-9","article-title":"Intralesional injection of cyclosporin in psoriasis","volume":"1","author":"Powles","year":"1988","journal-title":"Lancet"},{"key":"10.1111\/1523-1747.ep12505786_bb0045","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/0190-9622(90)70015-A","article-title":"Intralesional cyclosporine A in the treatment of psoriasis","volume":"22","author":"Ho","year":"1990","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/1523-1747.ep12505786_bb0050","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/337473a0","article-title":"Peptidyl-prolyl cis-trans isomerase is the cyclosporin A-binding protein cyclophilin","volume":"337","author":"Takahashi","year":"1989","journal-title":"Nature"},{"key":"10.1111\/1523-1747.ep12505786_bb0055","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/0167-5699(86)90005-8","article-title":"Psoriasis: A disease of abnormal keratinocyte proliferation induced by T-lymphocytes","volume":"7","author":"Valdimarsson","year":"1986","journal-title":"Immunol Today"},{"key":"10.1111\/1523-1747.ep12505786_bb0060","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/j.1365-2133.1987.tb05869.x","article-title":"The effects of cyclosporin A on T lymphocyte and dendritic cell sub-populations in psoriasis","volume":"116","author":"Baker","year":"1987","journal-title":"Br J Dermatol"},{"key":"10.1111\/1523-1747.ep12505786_bb0065","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/BF00431054","article-title":"Lymphocytes and macrophages of the epidermis and dermis in lesional psoriatic skin, but not epidermal Langerhans cells, are depleted by treatment with cyclosporin A","volume":"281","author":"Gupta","year":"1989","journal-title":"Arch Dermatol Res"},{"key":"10.1111\/1523-1747.ep12505786_bb0070","first-page":"12","article-title":"Additive and synergistic antiproliferative effects of cyclosporin A and gamma interferon on cultured human keratinocytes","volume":"131","author":"Nickoloff","year":"1988","journal-title":"Am J Pathol"},{"key":"10.1111\/1523-1747.ep12505786_bb0075","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1111\/1523-1747.ep12462009","article-title":"The effect of cyclosporin A on epidermal cells. II. Cyclosporin A inhibits proliferation of normal and transformed keratinocytes","volume":"90","author":"Furue","year":"1988","journal-title":"J Invest Dermatol"},{"key":"10.1111\/1523-1747.ep12505786_bb0080","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/1523-1747.ep12280279","article-title":"Topical cyclosporine A inhibits the phorbol ester induced hyperplastic inflammatory response but not protein kinase C activation in mouse epidermis","volume":"93","author":"Gupta","year":"1989","journal-title":"J Invest Dermatol"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X90913245?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X90913245?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,5]],"date-time":"2019-02-05T16:28:09Z","timestamp":1549384089000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X90913245"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1990,11]]},"references-count":15,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1990,11]]}},"alternative-id":["S0022202X90913245"],"URL":"https:\/\/doi.org\/10.1111\/1523-1747.ep12505786","relation":{},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[1990,11]]}}}